Pediatric Retina Bibliography

Retinopathy of Prematurity


CRYO-ROP Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity, one-year outcome--structure and function. Arch Ophthalmol. 1990;108(10):1408-1416. doi:10.1001/archopht.1990.01070120056029.

Vitrectomy for Stage 4A

Capone A Jr, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology. 2001;108(11):2068-2070. doi:10.1016/S0161-6420(01)00809-0.


ETROP Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684-1694. doi:10.1001/archopht.121.12.1684.

ROP Classification

International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123(7):991-999. doi:10.1001/archopht.123.7.991.

Remote ROP Diagnosis

Chiang MF, Keenan JD, Starren J, et al. Accuracy and reliability of remote retinopathy of prematurity diagnosis. Arch Ophthalmol. 2006;124(3):322-327. doi:10.1001/archopht.124.3.322.

Vitrectomy for Stage 4B

El Rayes EN, Vinekar A, Capone A Jr. Three-year anatomic and visual outcomes after vitrectomy for stage 4B retinopathy of prematurity. Retina. 2008;28(4):568-572. doi:10.1097/IAE.0b013e3181610f97.

Screening Guidelines

Fierson WM; American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131(1):189-195. doi:10.1542/peds.2012-2996.

Surgery Overview

Klufas MA, Patel SN, Chan RV. Surgical management of retinopathy of prematurity [published online August 26, 2014]. Dev Ophthalmol. 2014;54:223-233. doi:10.1159/000360470.


Quinn GE, Ying GS, Daniel E, et al; e-ROP Cooperative Group. Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. JAMA Ophthalmol. 2014;132(10):1178-1184. doi:10.1001/jamaophthalmol.2014.1604.

Anti-VEGF for ROP

VanderVeen DK, Melia M, Yang MB, et al. Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology [published online March 22, 2017]. Ophthalmology. 2017;124(5):619-633. doi:10.1016/j.ophtha.2016.12.025.



Murphree LA, Villablanca JG, Deegan WF III et al. Chemotherapy plus local treatment in management of intraocular retinoblastoma. Arch Ophthalmol. 1996;144(11):1348-1356. doi:10.1001/archopht.1996.01100140548005.

Intravitreal chemotherapy

Munier FL, Gaillard MC, Balmer A, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications [published online June 13, 2012]. Br J Ophthalmol. 2012;96(8):1078-1083. doi:10.1136/bjophthalmol-2011-30145.

RB genetics overview

Theriault BL, Dimaras H, Gallie BL, Corson TW. The genomic landscape of retinoblastoma: a review [published online May 22, 2013]. Clin Exp Ophthalmol. 2014;42(1):33-52. doi:10.1111/ceo.12132.

Pros and cons and various treatments

Abramson DH, Shields CL, Munier FL, Chantada GL. Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmol. 2015;133(11):1341-1347. doi:10.1001/jamaophthalmol.2015.3108.

Screening Guidelines

Skalet AH, Gombos DS, Gallie BL, et al. Screening children at risk for retinoblastoma: consensus report from the American Association of Ophthalmic Oncologists and Pathologists [published online ahead of print October 18, 2017]. Ophthalmology.  doi:10.1016/j.ophtha.2017.09.001.

Sickle Cell Retinopathy

Goldberg MF. Natural history of untreated proliferative sickle cell retinopathy. Arch Ophthalmol. 1971;85(4):428-437.

Elagouz M, Jyothi S, Gupta B, Sivaprasad DM. Sick cell disease and the eye: old and new concepts [published online May 10, 2010]. Surv Ophthalmol. 2010;55(4):359-77. doi:10.1016/j.survophthal.2009.

Familial Exudative Vitreoretinopathy

Ranchod TM, Ho LY, Drenser KA, Capone A Jr, Trese MT. Clinical presentation of familial exudative vitreoretinopathy [published online August 25, 2011]. Ophthalmology. 2011;118(10):2070-2075. doi:10.1016/j.ophtha.2011.06.020.

Kashani AH, Brown KT, Chang E, et al. Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy [published online July 5, 2014]. Ophthalmology. 2014;121(11):2220-2227. doi:10.1016/j.ophtha.2014.05.029.

Coats' Disease

Shields JA, Shields CL, Honavar SG, Demirci H, Cater J. Classification and management of Coats disease: the 2000 Proctor Lecture. Am J Ophthalmol. 2001;131(5):572-83. doi:10.1016/S0002-9394(01)00896-0.

Persistent Fetal Vasculature

Goldberg MF. Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV) LIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 1997;124(5):587-626. doi:10.1016/S0002-9394(14)70899-2.

Sisk RA, Berrocal AM, Feuer WJ, Murray TG. Visual and anatomic outcomes with or without surgery in persistent fetal vasculature. Ophthalmology. 2010;117(11):2178-2183. doi:10.1016/j.ophtha.2010.03.062.

Abusive Head Trauma

Forbes BJ, Rubin SE, Margolin E, Levin AV. Evaluation and management of retinal hemorrhages in infants with and without abusive head trauma. J AAPOS. 2010;14(3):267-273. doi:10.1016/j.jaapos.2010.03.002.

Levin AV, Alexander R, Binenbaum G, Forbes B, Jenny C; AAO Quality of Care Secretariat, Hoskins Center for Quality Eye Care. Abusive head trauma/shaken baby syndrome – 2015. American Academy of Ophthalmology Web site. Updated March 2015. Accessed January 22, 2018.

X-Linked Juvenile Retinoschisis

Sieving PA, MacDonald IM, Chan S. X-linked juvenile retinoschisis. GeneReviews. August 28, 2014. Accessed January 22, 2018.

Created February 2018